Leonard Braden Michael

CIK 000137360316 companiesZIONSVILLE, IN

SEC Profile

Transactions

Companies

Filings

CIK

0001373603

Recent Transactions

50 trades

Sale
Adverum Biotechnologies, Inc.
Common Stock
2025-12-04$4.19/sh−524,560→ 1,958,080 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2025-12-03$4.17/sh−222,925→ 2,428,640 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2025-12-02$4.20/sh−51,961→ 2,705,565 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2025-12-01$4.20/sh−300,000→ 2,757,526 total
Sale
ASTROTECH Corp$ASTC
Common Stock
2025-10-03$5.83/sh−9,166→ 0 total
Sale
ASTROTECH Corp$ASTC
Common Stock
2025-10-03$7.13/sh−220,410→ 0 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-05-30$1.01/sh−425,000→ 3,224,432 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-05-30$1.03/sh−7,000→ 3,217,432 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-05-28$1.16/sh−2,000,000→ 3,749,432 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-05-28$1.16/sh−100,000→ 3,649,432 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-05-28$1.09/sh−200,000→ 3,017,432 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-04-23$2.98/sh+50,000→ 191,800 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-04-22$3.00/sh+300,000→ 3,057,526 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-04-02$4.04/sh+15,209→ 2,757,526 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-03-31$4.38/sh+19,566→ 2,742,317 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-03-27$5.19/sh+16,593→ 141,800 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-03-27$5.19/sh+16,593→ 141,800 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-03-27$5.19/sh−16,593→ 141,800 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-03-26$5.04/sh+20,407→ 125,207 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-03-26$5.04/sh+20,407→ 125,207 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-03-26$5.04/sh+20,407→ 125,207 total
Purchase
Adverum Biotechnologies, Inc.
Common Stovk
2025-03-20$5.61/sh+30,600→ 2,722,761 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-03-19$4.94/sh+25,000→ 2,692,161 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-03-18$4.73/sh+44,341→ 2,667,161 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-03-18$4.60/sh+18,000→ 2,622,820 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-02-28$4.60/sh+85,068→ 2,604,820 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-02-27$4.46/sh+86,802→ 2,519,752 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-02-26$4.01/sh+164,886→ 2,432,950 total
Other
OnKure Therapeutics, Inc.$OKUR
Common Stock
2024-10-07+102,076→ 102,076 total
Other
OnKure Therapeutics, Inc.$OKUR
Common Stock
2024-10-07+345,739→ 345,739 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2024-09-25$1.50/sh+68,746→ 3,457,395 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2024-09-24$1.41/sh+29,600→ 3,388,649 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2024-09-18$1.40/sh+806→ 3,359,049 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2024-09-17$1.36/sh+55,300→ 3,358,243 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2024-09-16$1.37/sh+172,747→ 3,302,943 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2024-09-13$1.31/sh+150,000→ 3,130,196 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2024-09-12$1.40/sh+36,176→ 2,980,196 total
Purchase
Talis Biomedical Corp$TLIS
Common Stock
2024-09-06$1.48/sh+25,000→ 248,702 total
Purchase
Talis Biomedical Corp$TLIS
Common Stock
2024-09-05$1.40/sh+5,100→ 223,702 total
Purchase
Talis Biomedical Corp$TLIS
Common Stock
2024-09-03$4.00/sh+500→ 218,602 total
Purchase
Talis Biomedical Corp$TLIS
Common Stock
2024-08-30$4.25/sh+151→ 218,602 total
Purchase
Talis Biomedical Corp$TLIS
Common Stock
2024-08-28$3.96/sh+1,215→ 217,951 total
Purchase
Talis Biomedical Corp$TLIS
Common Stock
2024-08-26$3.90/sh+13,167→ 216,736 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2024-08-14$1.41/sh+100,487→ 2,944,020 total
Purchase
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-08-14$1.04/sh+1,500,000→ 5,749,432 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2024-08-13$1.39/sh+171,339→ 2,843,533 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-08-05$1.24/sh+206,025→ 14,250,000 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-08-02$1.29/sh+167,544→ 14,043,975 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-07-31$1.33/sh+100,000→ 13,876,421 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-07-30$1.30/sh+173,730→ 13,776,421 total

Companies

Recent Filings

Address

65 E CEDAR - SUITE 2

ZIONSVILLE, IN, 46077

View on SEC.gov